The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study
Open accessAbstract
Objectives This study was designed to evaluate the efficacy of atenolol for the long-term management of patients with vasovagal syncope. The primary hypothesis was that atenolol is not superior to placebo for the treatment of vasovagal syncope. Background There is no definitive well-controlled analysis of the efficacy of beta-adrenergic blocking agents in patients with recurrent vasovagal syncope. Methods This is a prospective, randomized, double-blind, placebo-controlled study. Fifty patients with recurrent vasovagal syncope were included (at least two episodes in the last year). A baseline tilt test was performed. Twenty patients (40%) had a positive tilt test. Intravenous atenolol prevented a second positive tilt in five patients. The patients were randomized to receive either atenolol or a placebo (26 patients atenolol 50 mg/day, 24 patients placebo). The follow-up procedure lasted one year. The primary end point of the study was the time to first recurrence of syncope. Results In the intention-to-treat analysis, the group treated with atenolol had a similar number of patients with recurrent syncopal episodes as the placebo group. The Kaplan-Meier actuarial estimates of time to first syncopal recurrence showed that the probability of remaining free of syncope drops similarly in both groups and that there was no statistical difference between both curves (patients treated with atenolol vs. the placebo) with a log-rank test p value of 0.4517. Conclusions The recurrence of n…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adequately designed and controlled randomized studies have found that beta-blockers are not effective for treating vasovagal syncope.”
In the citing paper
“Atenolol was no more effective than placebo in preventing recurrent syncope in another double-blind randomized clinical trial.121”
In the citing paper
“Beta-blockers failed to be effective in VVS in two randomized double-blind controlled trials. 279,280”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [279]
Citations
Cites
Almquist, A., Goldenberg, I. F., Milstein, S., Chen, M.-Y., Chen, X., Hansen, R., Gornick, C. C., & Benditt, D. G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200603 · Cited by 651
(1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00024-2 · Cited by 632
The North American vasovagal pacemaker study (VPS)
Connolly, S., Sheldon, R., Roberts, R., & Gent, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00549-x · Cited by 474
Sutton, R., Brignole, M., Menozzi, C., Raviele, A., Alboni, P., Giani, P., & Moya, A. (2000) · Circulation · doi:10.1161/01.cir.102.3.294 · Cited by 407
Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices
Forcinito, M. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80209-8 · Cited by 399
Di Girolamo, E., Di Iorio, C., Sabatini, P., Leonzio, L., Barbone, C., & Barsotti, A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00694-9 · Cited by 322
Gregoratos, G., Conill, A. M., Hlatky, M. A., Fellows, C., Silka, M. J., Ritchie, J., Eagle, K., Ryan, T., & Garson, A. (1998) · Journal of the American College of Cardiology · Cited by 306
Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons
Waxman, M. B., Yao, L., Cameron, D. A., Wald, R. W., & Roseman, J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)91076-x · Cited by 257
Midodrine: a role in the management of neurocardiogenic syncope
Ward, C. R., Gray, J. C., Gilroy, J. J., & Kenny, R. A. (1998) · Heart · doi:10.1136/hrt.79.1.45 · Cited by 249
Evaluation of Syncope by Upright Tilt Testing with Isoproterenol: A Nonspecific Test
Kapoor, W. N., & Brant, N. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-5-358 · Cited by 234
Research works printed but not linked: 2
- Brignole, 1999, Dual-chamber pacing is efficacious in treatment of neurally-mediated tilt positive cardioinhibitory syncope; pacemaker versus no therapy, Circulation, 100, 3387
- Fitzpatrick, 1991, A randomized trial of medical therapy in “malignant vasovagal syndrome or neurally-mediated bradycardia/hypotension syndrome”, Eur J Cardiac Pacing Electrophysiol, 2, 99
Cited by
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), societies, E. B. T. F., European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp298 · Cited by 2,040
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
“Atenolol was no more effective than placebo in preventing recurrent syncope in another double-blind randomized clinical trial.(121) However, in a meta analysis of a prespecified, prestratified substudy of POST 1 and a large earlier observational study, there was evidence of benefit in patients older than 40 years.”
BackgroundGuidelines on management (diagnosis and treatment) of syncope
Brignole, M. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2739 · Cited by 951
Guidelines on Management (diagnosis and treatment) of syncope ? update 2004
(2004) · Europace · doi:10.1016/j.eupc.2004.08.008 · Cited by 652
Metadata
- Authors
- Madrid, A. H., Ortega, J., Rebollo, J. G., Manzano, J. G., Segovia, J. G., Sánchez, A., Peña, G., & Moro, C.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Corresponding author
- Moro, Concepción
- ORCID
- Ortega, Javier
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 37
- Issue
- 2
- Pages
- 554-559
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2167029785
- Cited by
- 205
- References
- 37
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 2 · 2016: 4 · 2015: 8 · 2014: 2 · 2013: 9 · 2012: 8
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4548 d)
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
- Keywords
- atenolol, neurally mediated syncope, vasovagal syncope, beta-blockers, syncope recurrence, tilt table test
- MeSH terms
- Adolescent, Adrenergic beta-Antagonists, Adult, Aged, Atenolol, Double-Blind Method, Female, Humans, Male, Middle Aged, Prospective Studies, Recurrence, Treatment Failure, Tilt-Table Test, Syncope, Vasovagal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. https://app.cochat.ai/papers/10.1016/s0735-1097(00)01155-4
- The paper
- Madrid, A. H., Ortega, J., Rebollo, J. G., Manzano, J. G., Segovia, J. G., Sánchez, A., Peña, G., & Moro, C. (2001). Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(00)01155-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.